SCHEMBL7811377

SCHEMBL7811377

Cc1cc(-c2nc3c(s2)C(=O)c2ccccc2C3=O)oc1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 7/20 0.52
▸ TDO2 P48775 5/20 0.52
▸ MAPT P10636 4/20 0.36
▸ RAB9A P51151 4/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ GLA P06280 2/20 0.35
▸ NPC1 O15118 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ MAOB P27338 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ APAF1 O14727 1/20 0.34
▸ TDP2 O95551 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7811891 0.81 IDO1 (0.55) IDO1TDO2MAPTSMN1; SMN2CYP1A2
SCHEMBL7807731 0.79 IDO1 (0.52) IDO1TDO2MAPTRAB9ASMN1; SMN2
SCHEMBL7808342 0.76 IDO1 (0.55) IDO1TDO2MAPTRAB9ASMN1; SMN2
SCHEMBL7814769 0.76 IDO1 (0.55) IDO1TDO2MAPTRAB9ASMN1; SMN2
SCHEMBL7813124 0.76 IDO1 (0.55) IDO1TDO2MAPTRAB9ASMN1; SMN2
SCHEMBL7816639 0.75 IDO1 (0.57) IDO1TDO2MAPTALDH1A1MAOB
SCHEMBL7805785 0.75 IDO1 (0.53) IDO1TDO2MAPTRAB9ASMN1; SMN2
SCHEMBL7812948 0.74 IDO1 (0.52) IDO1TDO2MAPTRAB9ASMN1; SMN2
SCHEMBL7805846 0.73 IDO1 (0.48) IDO1TDO2MAPTRAB9ASMN1; SMN2
SCHEMBL7808047 0.72 IDO1 (0.79) IDO1TDO2ALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 — — EP claimed
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 — — EP disclosed
US-6262095-B1 TREATMENT OF ILLNESS ASSOCIATED WITH AN ALTERATION IN VENOUS FUNCTION AND/OR INFLAMMATORY EDEMA LABORATOIRE INNOTHERA (FR) 2001-07-17 — — US disclosed
EP-0876356-A1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF LABORATOIRE INNOTHERA Société Anonyme (FR) 1998-11-11 — — EP disclosed
WO-1997021684-A1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF LABORATOIRE INNOTHERA, SOCIETE ANONYME (FR) 1997-06-19 — — WO disclosed
Send feedback